Improving the Performance of Specialty Pharmacists in the Care of Patients With Pulmonary Arterial Hypertension

Health-System Edition, March 2019, Volume 8, Issue 2

FACULTY:

James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan

EDUCATIONAL OBJECTIVES:

At the completion of this activity, the participant will be able to:

  • Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
  • Identify patients hwho are at high risk for major bleeding secondary to DOAC use
  • Examine current and emerging DOAC reversal agents and their safety and efficacy
  • Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignetttes.

TARGET AUDIENCE: Health-system pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: March 15, 2019

EXPIRATION DATE: March 15, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.